Platelet prostanoid receptors.
Prostaglandins (PGs) and thromboxanes are important modulators of platelet activation, and there is strong evidence to support the existence of distinct thromboxane, prostacyclin, PGD2 and PGE2 receptors on the platelet plasma membrane. In this review, each of these platelet prostanoid receptors is discussed in detail, with respect to their receptor pharmacology, molecular biology and signal transduction, and as to any therapeutic implications of the development of specific agonists and/or antagonists. In addition, it considers the possibility that there are separate vascular receptors for 8-epi PGF2 alpha, which are not present on the platelet.
Armstrong
R A
RA
Department of Dietetics & Nutrition, Queen Margaret College, Edinburgh, Scotland.
D001792:Blood Platelets / Q000378:metabolism*; D006801:Humans; D044006:Receptors, Epoprostenol; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin / Q000819:agonists / Q000097:blood* / Q000235:genetics; D018078:Receptors, Prostaglandin E / Q000819:agonists / Q000097:blood / Q000235:genetics; D017482:Receptors, Thromboxane / Q000097:blood* / Q000235:genetics; D015398:Signal Transduction
D044006:Receptors, Epoprostenol; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; D017482:Receptors, Thromboxane; C034671:prostaglandin F2alpha receptor; C036293:prostaglandin D2 receptor